Steven Y. Yap

Steven Y. Yap

Auto-generated profile, based on publicly available information

Steven Y. Yap

Department of Chemistry, University College London, 20 Gordon Street, London, WC1H 0AJ, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2021 in Brain
Verified
Journal Article
Open access
PDF file
SYSteven Y Yap
Steven Y Yap
BFBarbara Frias
Barbara Frias
MWMelissa C Wren
Melissa C Wren
MSMichael Schöll
Michael Schöll
NFNick C Fox
Nick C Fox
KSKerstin Sander
Kerstin Sander
A next generation of tau PET tracers for the imaging of Alzheimer’s disease and other dementias has recently been developed. Whilst the new compounds have now entered clinical studies, there is limited information available to assess their suitability for clinical applications. Head-to-head comparisons are urgently needed to understand differences in the radiotracer binding profiles. We characterized the binding of the tau tracers PI2620, RO948, MK6240 and JNJ067 in human post-mortem brain tissue from a cohort of 25 dementia cases and age-matched controls using quantitative phosphorimaging with tritium-labelled radiotracers in conjunction with phospho-tau specific immunohistochemistry. The four radiotracers depicted tau inclusions composed of paired helical filaments with high specificity, both in cases with Alzheimer’s disease and in primary tauopathy cases with concomitant Alzheimer’s disease pathology. In contrast, cortical binding to primary tauopathy in cases without paired helical filament tau was found to be within the range of age-matched controls. Off-target binding to monoamine oxidase B has been overcome, as demonstrated by heterologous blocking studies in basal ganglia tissue. The high variability of cortical tracer binding within the Alzheimer’s disease group followed the same pattern with each tracer, suggesting that all compounds are suited to differentiate Alzheimer’s disease from other dementias.

25 June 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SYSteven Y. Yap
Steven Y. Yap
TPThomas W. Price
Thomas W. Price
HSHuguette Savoie
Huguette Savoie
RBRoss W. Boyle
Ross W. Boyle
GSGraeme J Stasiuk
Graeme J Stasiuk
A theranostic conjugate for use as a positron emission tomography (PET) radiotracer and as a photosensitiser for photodynamic therapy (PDT) has been synthesised. A water-soluble porphyrin was coupled with the bifunctional chelate, H4Dpaa.ga. This conjugate is capable of rapid 68Ga complexation under physiological conditions; with 93% and 80% radiochemical yields achieved, at pH 4.5 and pH 7.4 respectively, in 15 min at 25 °C. Photocytotoxicity was evaluated on HT-29 cells and showed the conjugate was capable of >50% cell death at 50 μM upon irradiation with light, while causing minimal toxicity in the absence of light (>95% cell survival).

18 February 2020 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
TPThomas W. Price
Thomas W. Price
SYSteven Y. Yap
Steven Y. Yap
RGRaphaël Gillet
Raphaël Gillet
HSHuguette Savoie
Huguette Savoie
Loïc J. CharbonnièreLoïc J. Charbonnière
Loïc J. Charbonnière
GSGraeme J Stasiuk
Graeme J Stasiuk

12 August 2020 in Chemical Communications
Verified
Journal Article
Open access
PDF file
SYSteven Y. Yap
Steven Y. Yap
HSHuguette Savoie
Huguette Savoie
IRIsaline Renard
Isaline Renard
BBBenjamin P. Burke
Benjamin P. Burke
HSHarry C. Sample
Harry C. Sample
GSGraeme J Stasiuk
Graeme J Stasiuk
“Click” chemistry was utilised to synthesis multifunctional theranostic drugs with therapeutic, diagnostic, and prostate-cancer targeting capabilities, paving a path towards “personalised” medicine ultimately improving patients' quality of life.

2 April 2022 in Chemical Communications
Verified
Journal Article
Open access
PDF file
RSRichard J. Spears
Richard J. Spears
ACAlina Chrzastek
Alina Chrzastek
SYSteven Y. Yap
Steven Y. Yap
KKKersti Karu
Kersti Karu
AAAbil E. Aliev
Abil E. Aliev
VCVijay Chudasama
Vijay Chudasama
Herein we report the remarkable stability of C-terminal thiophosphonium species on small molecules, peptides and proteins.

2 May 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
SYSteven Y. Yap
Steven Y. Yap
TBTobias Butcher
Tobias Butcher
RSRichard J. Spears
Richard J. Spears
CMClíona McMahon
Clíona McMahon
ITIoanna A. Thanasi
Ioanna A. Thanasi
VCVijay Chudasama
Vijay Chudasama
Use of dehydroalanine-forming reagents to enable the first example of differentially modifying the native solvent accessible cysteines on an antibody.